Egerton Capital LH trades
John Armitage
John Armitage Labcorp Holdings Inc stake
total: 222
Trades details
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2018 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2018 Q3
According to 2026 Q3 report, John Armitage doesn't hold any Labcorp Holdings Inc (LH) shares. To date, the estimated cost basis is nearly $179.53 for "buy" trades and estimated average "sell" price is $179.53. Egerton Capital first purchased LH in 2018 Q2, initially acquiring 841,025 shares. Since the initial investment in Labcorp Holdings Inc (LH), Egerton Capital has made 1 more transaction.
When did John Armitage sell Labcorp Holdings Inc (LH)?
John Armitage sold off the entire Labcorp Holdings Inc (LH) position in 2018 Q3.
When did John Armitage buy Labcorp Holdings Inc (LH)?
John Armitage first invested in Labcorp Holdings Inc (LH) in 2018 Q2 at the reported quarter-end price of $179.53 per share.
What's the cost basis of Egerton Capital's LH stake?
The estimated cost basis for Labcorp Holdings Inc (LH) stake is around $179.53 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $179.53
- Weighted AVG sell price:
- $179.53
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.